文献速递前列腺增生与排尿功能障碍

UroMonitor首次人体试验:无导管无线动态膀胱压力监测仪

First in Human Subjects Testing of the UroMonitor: A Catheter-free Wireless Ambulatory Bladder Pressure Monitor.
PubMed 文献 · J Urol · 2023-06-09

本研究纳入11例因膀胱过度活动症症状接受尿动力学检查的成年女性患者,在尿动力学检查中同步使用无导管无线膀胱内压力传感器UroMonitor,评估其压力数据准确性及人体使用的安全性和可行性。结果显示UroMonitor未显著改变尿动力学参数,能捕获98%(85/87)的排尿和非排尿尿动力学事件,所有受试者仅留置UroMonitor即可排尿且残余尿量低,动态疼痛评分中位数为0(0-2),无术后感染或排尿行为改变。

要点

  • UroMonitor未显著改变尿动力学检查中的膀胱容量、感觉或尿流率。
  • UroMonitor捕获了98%(85/87)的排尿和非排尿尿动力学事件。
  • 所有受试者仅留置UroMonitor即可排尿且残余尿量低,无术后感染。

核心结论

  • UroMonitor是首个可在人体实现无导管遥测动态膀胱压力监测的设备。
  • UroMonitor似乎安全且耐受良好,不阻碍下尿路功能,与尿动力学相比能可靠识别膀胱事件。

研究设计与样本

  • 首次人体试验,纳入11例因膀胱过度活动症症状接受尿动力学检查的成年女性患者。
  • 基线尿动力学后经尿道置入UroMonitor并经膀胱镜确认位置,随后同步进行第二次尿动力学检查。
  • 移除尿动力学导管后,UroMonitor在患者走动和私下排尿时遥测膀胱压力,采用视觉模拟疼痛量表(0-5)评估不适。

主要发现

  • UroMonitor未显著改变尿动力学检查中的膀胱容量、感觉或尿流率。
  • 所有受试者中UroMonitor置入和移除均容易。
  • UroMonitor捕获了98%(85/87)的排尿和非排尿尿动力学事件。
  • 所有受试者仅留置UroMonitor即可排尿且残余尿量低。
  • UroMonitor动态疼痛评分中位数为0(0-2),无术后感染或排尿行为改变。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Urodynamics is the standard method of diagnosing bladder dysfunction, but involves catheters and retrograde bladder filling. With these artificial conditions, urodynamics cannot always reproduce patient complaints. We have developed a wireless, catheter-free intravesical pressure sensor, the UroMonitor, which enables catheter-free telemetric ambulatory bladder monitoring. The purpose of this study was twofold: to evaluate accuracy of UroMonitor pressure data, and assess safety and feasibility of use in humans. MATERIALS AND METHODS: Eleven adult female patients undergoing urodynamics for overactive bladder symptoms were enrolled. After baseline urodynamics, the UroMonitor was transurethrally inserted into the bladder and position was confirmed cystoscopically. A second urodynamics was then performed with the UroMonitor simultaneously transmitting bladder pressure. Following removal of urodynamics catheters, the UroMonitor transmitted bladder pressure during ambulation and voiding in private. Visual analogue pain scales (0-5) were used to assess patient discomfort. RESULTS: The UroMonitor did not significantly alter capacity, sensation, or flow during urodynamics. The UroMonitor was also easily inserted and removed in all subjects. The UroMonitor reproduced bladder pressure, capturing 98% (85/87) of voiding and nonvoiding urodynamic events. All subjects voided with only the UroMonitor in place with low post-void residual volume. Median ambulatory pain score with the UroMonitor was rated 0 (0-2). There were no post-procedural infections or changes to voiding behavior. CONCLUSIONS: The UroMonitor is the first device to enable catheter-free telemetric ambulatory bladder pressure monitoring in humans. The UroMonitor appears safe and well tolerated, does not impede lower urinary tract function, and can reliably identify bladder events compared to urodynamics.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Frainey BT, Majerus SJA, Derisavifard S, et al. First in Human Subjects Testing of the UroMonitor: A Catheter-free Wireless Ambulatory Bladder Pressure Monitor. J Urol. 2023. PMID: 37293725. doi:10.1097/JU.0000000000003451

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。